Budding Entrepreneurial Success at Weill Cornell Medicine-Qatar
September 18, 2023
Dr. Hani Najafi, an assistant professor of cell and developmental biology, was the first WCM-Q participant in the $100K Biomedical Business Plan Challenge Pitch Day competition hosted by the BioVenture eLab. Enterprise Innovation asked him to share his latest study that can lead to potential therapies for cardiometabolic diseases and obesity.
Entrepreneurship and the Power of Story Telling
September 12, 2023
An Accelerating BioVenture Innovation (ABI) student asked Dr. Erandi De Silva, the guest speaker of the Fall 2023 cohort kickoff event hosted on Aug. 29 in a packed Uris Auditorium, how she was able to convince venture capitalists with an idea of gene therapy development and operationalization on paper.
Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests
August 9, 2023
A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
Stroke Detection and Education App Shows Encouraging Results in Pilot Program
July 24, 2023
In 2019, Dr. Evan Noch, an assistant professor of neurology at Weill Cornell Medicine, led a team of graduate students to win the “Most Impactful Hack” award at the third annual NYC Health Hackathon. After completing a pilot program at the Burke Neurological Institute, Destroke is set to refine its prototype, expand usership and conduct randomized trials with larger patient samples, including one at Weill Cornell Medicine.
High-Risk, High-Reward
July 5, 2023
Dr. Lisa Placanica (B.A. ’00, Ph.D. ’09), the senior managing director for CTL at Weill Cornell, and Dr. Juan Cubillos-Ruiz, the William J. Ledger, M.D., Distinguished Associate Professor for Infection and Immunology in Obstetrics and Gynecology, discuss how the ecosystem for innovation at Weill Cornell Medicine provides the support entrepreneurial faculty and students need to turn their promising research into commercially viable drugs and other treatments.
Personal and Professional: An Immunologist’s Quest to Cure HIV
June 23, 2023
To celebrate Pride Month, Enterprise Innovation spoke with Dr. Brad Jones, an associate professor of immunology in medicine, about his mission to find a cure for HIV and the recent progress in his research.
Scientists Pitch Medical Innovations at 2023 Biomedical Business Plan Challenge
June 16, 2023
Standing on the stage at Uris Auditorium on June 1, Dr. Joe Zhou, an associate professor in regenerative medicine in medicine at Weill Cornell Medicine, made the case for the necessity of developing new approaches to treat diabetes, a disease he called “a true epidemic of the modern world.”
Biomedical Engineering Symposium Showcases Research, Facilitates Collaborations
June 15, 2023
A two-day intercampus event, the “Biomedical Engineering Symposium: Tools to Transform Discovery and Care,” brought together dozens of engineers, scientists and practitioners from across Cornell to share research and foster collaborations, with the goal of building the foundation for new, cutting-edge medical treatments and devices.
Cornell Engineering and Weill Cornell Medicine Pilot M.D.-M.Eng. Degree
May 10, 2023
As part of a new cross-college initiative designed to accelerate engineering innovations in medicine, Cornell Engineering is piloting an M.D.-M.Eng. program that allows medical students at Weill Cornell Medicine to earn a one-year professional Master of Engineering degree while they are in medical school.
App-Based Communication Tool Receives NIH Funding
May 8, 2023
VoiceLove LLC, a startup founded by two Weill Cornell Medicine physicians, was awarded a $3 million fast-track Phase 1-Phase 2 grant by the National Institute on Aging of the National Institutes of Health to further develop and test in clinical trial a prototype app designed to help critically ill patients in hospital intensive care units connect with their families.